Pharmacotherapy for smoking cessation (Q37362638)

19 August 2017

1 reference

title

Pharmacotherapy for smoking cessation. (English)

1 reference

19 August 2017

0 references

3

Giovanni Viegi

1 reference

19 August 2017

Laura Carrozzi

1

1 reference

19 August 2017

Francesco Pistelli

series ordinal

2

1 reference

19 August 2017

publication date

1 October 2008

1 reference

Therapeutic advances in respiratory disease

19 August 2017

published in

1 reference

19 August 2017

volume

2

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

301-317

1 reference

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Nicotine receptor partial agonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Opioid antagonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Tolerability and pharmacokinetics of single and repeated doses of nicotine with The Straw, a novel nicotine replacement product

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Brain monoamine oxidase A inhibition in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bupropion for weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

The cost-effectiveness of the English smoking treatment services: evidence from practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Clonidine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Pharmacotherapy for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bupropion: a review of its use in the management of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bupropion as an aid to smoking cessation: a review of real-life effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Metabolism and disposition kinetics of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bromocriptine reduces cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Passive immunization against nicotine attenuates nicotine discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Bromocriptine use is associated with decreased smoking rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Outcomes of bupropion therapy for smoking cessation during routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A vaccine for nicotine dependence: targeting the drug rather than the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Chronic tolerance to nicotine in humans and its relationship to tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Nicotine and the central nervous system: biobehavioral effects of cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Treating tobacco dependence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Non-nicotinic therapies for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Acute effect of glucose tablets on desire to smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Individual differences in preferences for and responses to four nicotine replacement products

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Smoking cessation guidelines for health professionals: an update. Health Education Authority

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

Oral nicotine solution for smoking cessation: a pilot tolerability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808096136

21 January 2018

Identifiers

DOI

10.1177/1753465808096136

1 reference

19 August 2017

1 reference